结合过敏原特异性免疫疗法与严重喘中的生物药物:反直觉还是理性?
Désirée Larenas-Linnemann1, Zuzana Diamant2, Milos Jesenak3
1Centro de Excelencia en Asma y Alergia Larenas, Hospital Médica Sur, Mexico City, Mexico.
概括
与生物疗法相结合的过敏原免疫疗法 (AIT) 可能有利于严重过敏喘患者. 这种方法可以帮助实现长期控制和潜在的持续缓解,即使在治疗停止后.
科学领域:
- 免疫学 免疫学 免疫学
- 过敏和喘研究研究
背景情况:
- 严重的喘往往涉及eosinophilic和过敏性内型,经常与过敏性鼻炎 (AR) 一起发生.
- 过敏原免疫疗法 (AIT) 提供了对过敏呼吸道疾病的疾病修饰,但需要疾病控制,这对容易恶化的严重喘患者构成挑战.
研究的目的:
- 总结了在严重过敏性喘中将AIT与生物疗法结合的临床试验.
- 讨论AIT作为接受生物制剂的患者的附加治疗的好处和缺点.
主要方法:
- 对研究AIT (皮下或舌下) 与生物药物 (奥马利祖马布,杜皮卢马布,特泽佩卢马布) 结合的里程碑式临床试验的综述.
- 分析研究检查这些组合疗法的机制和临床结果的研究.
主要成果:
- 生物疗法可以稳定严重喘患者,使他们在6-12个月后成为补充AIT的候选人.
- 组合疗法显示提高了安全性,耐受性和潜在的疗效.
- AIT可能有助于实现临床缓解,可能在治疗后持续.
结论:
- 将AIT与生物疗法结合起来是治疗严重过敏喘的可行策略.
- 这种组合疗法有望改善长期结果,并在精选患者中实现持续缓解.
相关概念视频
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
161
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
161
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
139
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
139
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Allergic Reactions
27.2K
Overview
27.2K
Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K


